ASSESSMENT OF CLINICAL PRESENTATION, HISTOPATHOLOGIC CHARACTERISTICS AND THERAPEUTIC OUTCOMES IN EYELID SEBACEOUS GLAND CARCINOMA: CASES REPORT

Kiều Hoa Mai, Anh Tuấn Hoàng, Quốc Anh Nguyễn, Ngân Hà Nguyễn

Main Article Content

Abstract

Sebaceous gland carcinoma (SGC) of the eyelid is a rare but highly malignant tumor, most commonly arising from the Meibomian glands or the glands of Zeis. The disease primarily affects elderly individuals, particularly women, and is more frequently located on the upper eyelid. Clinically, SGC often presents with nonspecific features and may be misdiagnosed as benign conditions such as chalazion or chronic blepharitis, leading to delayed diagnosis and treatment. Histopathologically, the tumor is characterized by proliferation of cells with clear lipid-containing cytoplasm and basophilic nuclei; in some cases, immunohistochemical staining is required to confirm sebaceous differentiation. Wide local excision with histologically negative margins remains the mainstay of treatment. This report presents cases of eyelid SGC diagnosed and treated at the Vietnam National Eye Hospital, describing their clinical, histopathological characteristics, and treatment outcomes. The study aims to raise awareness of this rare but aggressive malignancy and emphasize the importance of early diagnosis and complete surgical excision in improving patient prognosis.

Article Details

References

Sendul SY, Akpolat C, Yilmaz Z, Eryilmaz OT, Guven D, Kabukcuoglu F. Clinical and pathological diagnosis and comparison of benign and malignant eyelid tumors. Journal Français d’Ophtalmologie. 2021;44(4):537-543.S
2. Yasinzai AQK, Goodbee M, Ahweyevu J, et al. Sebaceous carcinoma of the eyelid: demographical analysis and role of surgery in the management. Eur J Plast Surg. 2023;46(6):1011-1018.
3. Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009;115(1):158-165.
4. A retrospective study of 2228 cases with eyelid tumors. Int J Ophthalmol. Published online November 18, 2018.
5. Ul Kadir SM, Rani Mitra M, Rashid R, et al. Clinicopathological Analysis and Surgical Outcome of Eyelid Malignancies: A Study of 332 Cases. Kimyai Asadi A, ed. Journal of Skin Cancer. 2022;2022:1-9.
6. Kaliki S, Bothra N, Bejjanki KM, et al. Malignant Eyelid Tumors in India: A Study of 536 Asian Indian Patients. Ocul Oncol Pathol. 2019;5(3):210-219.
7. Hoàng Anh Tuấn. Nghiên cứu một số đặc điểm lâm sàng, mô bệnh học và hóa mô miễn dịch ung thư biểu mô tế bào đáy và tuyến bã ở mi mắt. năm 2012.
8. Kaliki S, Ayyar A, Nair AG, Mishra DK, Reddy VAP, Naik MN. Neoadjuvant Systemic Chemotherapy in the Management of Extensive Eyelid Sebaceous Gland Carcinoma: A study of 10 Cases. Ophthalmic Plastic & Reconstructive Surgery. 2016;32(1):35-39.
9. Cicinelli MV, Kaliki S. Ocular sebaceous gland carcinoma: an update of the literature. Int Ophthalmol. 2019;39(5):1187-1197.
10. Owen JL, Kibbi N, Worley B, et al. Sebaceous carcinoma: evidence-based clinical practice guidelines. The Lancet Oncology. 2019;20(12): e699-e714.